EMBECTA CORP. Operating Lease Cost
EMBECTA CORP. (EMBC) reported Operating Lease Cost of $4.90 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-07
- EMBECTA CORP. operating lease, cost for the quarter ending 2026-03-31 was $2.90M, a 0.00% change year-over-year.
- EMBECTA CORP. operating lease, cost for the quarter ending 2025-12-31 was $1.70M.
- EMBECTA CORP. operating lease, cost for the quarter ending 2025-09-30 was $1.90M.
- EMBECTA CORP. operating lease, cost for the quarter ending 2025-03-31 was $2.90M.
- EMBECTA CORP. operating lease, cost for fiscal 2025 was $6.30M, a 16.00% decline from fiscal 2024.
- EMBECTA CORP. operating lease, cost for fiscal 2024 was $7.50M, a 66.67% increase from fiscal 2023.
- EMBECTA CORP. operating lease, cost for fiscal 2023 was $4.50M.
- EMBECTA CORP. operating lease, cost for fiscal 2022 was $0.00.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.90M 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $2.90M 10-Q · filed 2026-05-05 | $4.60M derived: sum of 2 quarters · filed 2026-05-05 | $6.50M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2025-12-31 | $1.70M 10-Q · filed 2026-02-05 | $3.60M derived: sum of 2 quarters · filed 2026-02-05 | ||
| 2025-09-30 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $6.30M 10-K · filed 2025-11-25 | ||
| 2025-06-30 | $4.40M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $2.90M 10-Q · filed 2026-05-05 | |||
| 2024-09-30 | $7.50M 10-K · filed 2025-11-25 | |||
| 2023-12-31 | $2.00M 10-Q · filed 2026-02-05 | |||
| 2023-09-30 | $4.50M 10-K · filed 2025-11-25 | |||
| 2022-09-30 | $0.00 10-K · filed 2024-12-11 | |||
| 2021-09-30 | $0.00 10-K · filed 2023-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |